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Introduction
Blepharoptosis (or simple ptosis) is the 
drooping or inferior displacement of the 
upper eyelid (1). It is diagnosed measur-
ing palpebral fissure height, marginal reflex 
distance, upper eyelid crease and levator 
function (2). It must also be differentiated 
by pseudoptosis (3). The causes of ptosis 
can be classified into two categories: con-
genital and acquired. Congenital ptosis, 
which is an anomaly of the muscle elevator 
development, is unilateral in 69% of cases, 
but can also be symmetrical or asymmetri-
cal bilateral (4). Other causes of congenital 
ptosis are the Marcus Gunn jaw-winking 
syndrome, the Duane’s syndrome and the 
congenital Horner’s syndrome (5). Acquired 
ptosis are classified into several subcatego-
ries: mechanical, myogenic, neuromuscu-
lar, neurogenic and cerebral (5). The most 
common cause of ptosis is mechanical, spe-
cifically aponeurotic (senile or young involu-
tion) in which there is bilateral ptosis due to 
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mime a benign disease; however, they could also be the symptoms of a systemic malignancy.
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a progressive relaxation or dehiscence of the 
levator aponeurosis; in young people, the 
causes are rubbing eyes and prolonged use 
of contact lenses. Other causes of mechani-
cal ptosis are as follows: inflammation or 
infiltration of the eyelid (with malignancy or 
amyloid), dermatochalasis, tumours of the 
orbit or lid, post-surgical edema, chalazion, 
a lost contact lens in the superior fornix or 
a scar (5). Among non-mechanical acquired 
ptosis, we distinguish the following catego-
ries: myogenic (chronic progressive exter-
nal ophthalmoplegia, myotonic dystrophy 
and oculopharyngeal muscular dystrophy), 
neuromuscular (myasthenia gravis and 
botulism), neurogenic (Horner’s syndrome, 
oculomotor paresis, Miller–Fisher syndrome 
and ophthalmoplegic migraine) and cer-
ebral (especially right hemisphere lesions) 
(5). Another cause of ptosis is tumour 
metastasis. Herein, we present a case of a 
47-year-old man who presented with uni-
lateral ptosis and blurred vision, due to a 
repetitive lesion that stemmed from meta-
static renal cell carcinoma (RCC). Although 
rare, many studies report RCC metastasis 
to orbits (6–8).
Case report
Written, informed consent was obtained from 
the patient for publication of the report and 
any accompanying images. A 47-year-old 
man was admitted to the Unit of Diagnostic 
Imaging Università Campus Bio-Medico di 
Roma for a brain magnetic resonance imag-
ing examination. He was referred to our hos-
pital because of narrowing of the left eyelid. 
The disorder was associated with occasional 
nuanced blurred vision.
At the level of the left orbit roof in the frontal 
bone, in-depth thin-film sequences showed 
a solid lesion likely to be extraconal bone 
departure, with expansive growth charac-
teristics (diameters of 23 × 15 × 25 mm). This 
was characterized by intermediate signal 
intensity on T1- and T2-weighted images, 
evidence of contrast enhancement and 
intra-orbital development at the upper-outer 
quadrant level. The deforming upper-side of 
the eyeball incorporated the lacrimal gland 
with no safe cleavage planes from the upper 
rectus, lateral rectus and the upper eyelid 
muscle. They were completely incorporated 
into the lesion (Figure 1). Total body com-
puted tomography (CT) showed numerous 
secondary mediastinal lymphadenopathy 
that were bilateral hilars (diameters right 
13 × 23 mm and left 36 × 23 mm) or subcari-
nal (diameters 39 × 25 mm).
At the upper pole of the left kidney was 
a partially exophytic lesion (diameters 
72 × 56 × 70 mm), which marked the upper 
caliceal group, with contextual necrotic phe-
nomena (Figure 2). Locoregional lumbar-
aortic lymphadenopathy with a maximum 
diameter of 20 mm, two repetitive lesions at 
the body (diameter 21 mm) (Figure 2A and 
B) and medial arm (diameter 10 mm) of the 
left adrenal gland, and nodulation of 8 mm 
in diameter in the right adrenal gland were 
also seen. In addition, multiple bone lesions 
in skeletal segments were examined. After 
CT staging, the patient was subjected to 
endoscopic ultrasound, and multiple speci-
mens at lymph-node stations 7 and 11L 
were collected for cytology. As a result of 
cytological sampling, the patient was diag-
nosed with RCC. The patient was subse-
quently followed up in another hospital for 
management.
Discussion
About 25–33% of RCC patients have metas-
tases at the first diagnosis (9). These are 
mainly detected in the lungs (75% of cases), 
regional lymph nodes (65%), bone (40%) and 
liver (40%). In 15% of cases, metastases to 
head and neck have been observed. Macro-
scopically, RCC metastases are highly vas-
cular and soft, elastic and yellowish white 
in color. Histological features are as follows: 
encapsulating connective tissue, clear cell 
borders, copious clear cytoplasm and round 
or oval nuclei (10). RCC is often noted to 
invade the local vascularization through the 
interlobular, arcuate and interlobar veins 
and metastasize through the systemic circu-
lation (6). Orbital involvement due to metas-
tasis usually presents with orbital mass, 
exophthalmos, lid edema, ptosis, diplopia 
and/or cranial nerve paralysis (11). Orbital 
metastases (OM) are relatively rare with the 
incidence ranging from 1% to 13% reported 
series of orbital tumours (12).
A US study, conducted on 100 patients, found 
a higher percentage of OM from the breast 
(53%), followed by lung (8%), melanoma (6%) 
and kidney (5%) (13). An Italian study, per-
formed on 93 patients, found the greatest per-
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centage of mammary origin (36%), followed by 
kidney (10%), lung (8%) and skin (6%) (14). 
Another study, carried out in Southern China 
on 46 patients, showed a higher percentage of 
nasopharyngeal origin (30%), followed by lung 
(8%), liver (6%), kidney (4%) and breast (4%) 
Figure 1.  Magnetic resonance imaging: Coronal T2 TSE sequence (A) and coronal SE T1 sequence 
with fat suppression (B), showing expansive lesion of probable bone origin with intraorbital devel-
opment, which appears isointense in T2 and shows contrast enhancement on T1 fat-suppressed 
sequence (white arrows).
Figure 2.  CT: axial scans during arterial (A) and venous (B) phases and coronal scan during venous 
phase (C) of the abdomen, show expansive lesion, partially exophytic, located in the upper pole of the 
left kidney (diameters 72 × 56 × 70 mm) with necrosis in the context (white arrows); it also observes 
repetitive lesion of the right adrenal gland body (diameter 20 mm) (A and B) (yellow arrows).
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(15). Finally, a Japanese study, performed on 
128 patients, found the greatest frequency of 
pulmonary origin (16%), followed by breast 
(15%), liver (14%), adrenal neuroblastoma 
(7%) and kidney (3%) (16).
OM from RCC and clear cell are rare; 
they can also develop after the removal of 
the primary tumour (17). RCC promotes 
angiogenic factors that promote tumour 
and ocular neovascularization (18). Tran-
sitional cell carcinoma of the renal pel-
vis constitutes about 15–20% of renal 
tumours in adults and 90% of the renal 
pelvis tumours; squamous cell cancer and 
adenocarcinoma constitute the remaining 
10% (19). Some cases of metastatic tran-
sitional cell tumour have been reported 
from the bladder to the choroid and orbit, 
whereas only one case of metastasis to the 
choroid from transitional cell carcinoma 
of the renal pelvis is reported (20, 21). 
Adult Wilms tumour is a rare tumour that 
tends to appear in advanced stage and 
has a poor prognosis (22). Only one case 
of metastasis to the eye (choroidal metas-
tases) from adult Wilms cancer is reported 
(23).
Conclusion
Symptoms such as exophthalmos, lid 
edema, diplopia, ptosis, cranial nerve 
paralysis or blurred vision could be the 
symptoms of a systemic malignancy. 
These must be investigated using avail-
able measures. Cytology and histology are 
invaluable tools in diagnostic pathology 
(24). In this case, cytology helped to iden-
tify metastatic RCC as the cause of unilat-
eral blepharoptosis.
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